Lack of Good News Drags on Market

Lack of Good News Drags on Market

Low expectations for China-trade talks and uncertainty about Fed action leave traders wary.

GrubHub Delivers for Investors as Citigroup Upgrades Stock to Buy

GrubHub Delivers for Investors as Citigroup Upgrades Stock to Buy

Food-ordering service can boost sales despite competition, and it may plan new partnerships, analyst says.

Dow Ends Lower, Stocks Fall as Powell Says Fed 'Grappling' with Rate Cut

Dow Ends Lower, Stocks Fall as Powell Says Fed 'Grappling' with Rate Cut

Major indexes declined Tuesday after Federal Reserve Chairman Jerome Powell hedged on a possible rate cut.

GrubHub Is Becoming More Appetizing

GrubHub Is Becoming More Appetizing

Chart patterns suggest the food delivery service company has bottomed out and may be turning.

Microsoft: Not Everyone Is So Bullish on The Tech Giant

Microsoft: Not Everyone Is So Bullish on The Tech Giant

Margins for Microsoft's Azure could never match those of Amazon's AWS, even at comparable scale, according to a Jeffries analyst.

What Is a Ticker Symbol? Definition and Examples

What Is a Ticker Symbol? Definition and Examples

In order to understand what is happening within any stock exchange, you first need to know what a ticker symbol is and how to read it. Find out more.

Go With the Flow

Go With the Flow

While many traders side with either bears or bulls, remember to embrace the ebb and flow of markets.

3 Signs You Might be Overpaying for a Stock

3 Signs You Might be Overpaying for a Stock

Warren Buffett recently said he overpaid for Berkshire Hathaway's stake in Kraft Heinz. To avoid following in his footsteps, here are three signs that you might be overpaying for a stock.

Wall Street Voices Skepticism on AbbVie's Aggressive Allergan Acquisition

Wall Street Voices Skepticism on AbbVie's Aggressive Allergan Acquisition

Despite the financial positivity, many analysts warn the deal could have hiccups ahead.

AbbVie Gets a Shot in the Arm With Allergan Buy, but Now Look Elsewhere

AbbVie Gets a Shot in the Arm With Allergan Buy, but Now Look Elsewhere

The deal makes sense for growth - and for Allergan shareholders - but now the price and uncertainty make this stock hard to swallow.